Researcher profile

Huajun Zhou

Huajun Zhou contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
1topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2026arXiv

A Breast Vision Pathology Foundation Model for Real-world Clinical Utility

Pathology foundation models have shown strong retrospective performance, but whether such systems can support clinically relevant use remains unclear. This challenge is particularly important in breast cancer, where pathological assessment serves as the gold standard for diagnosis and guides treatment planning, surgical decision-making and risk stratification across pre-, intra- and post-operative stages. Here we present \textbf{BRAVE}, a breast-adaptive pathology foundation model developed and evaluated using a total resource of 101,638 breast whole-slide images from 32 sources across Asia, Europe and North America. We assessed BRAVE across 34 tasks in 82 cohorts spanning pre-operative biopsy, intra-operative frozen section and post-operative resection, using an evidence chain comprising retrospective benchmarking, clinically challenging scenarios, workflow-oriented clinical impact simulations, prospective observational validation with the thresholds locked in the retrospective cohorts and crossover pathologist-AI interaction studies. Across these settings, BRAVE supported practical roles in the clinical workflow, including safe exclusion of low-risk cases from routine review, AI-assisted second-review rescue of initially missed positives and prioritization of cases for further assessment. In prospective validation across three centres, BRAVE excluded 76.9% of negative biopsy cases (NPV 0.953) and 70.1% of negative frozen-section cases (NPV 0.973), and triaged 78.8% of post-operative subtyping cases as high-confidence clear-cut cases (NPV 1.000). In reader studies, AI assistance improved balanced accuracy from 88.5% to 95.1% (OR 3.14, P<0.001), with better efficiency, confidence and inter-rater agreement. BRAVE-derived scores also independently predicted disease-free survival (adjusted HR 4.79, P<0.001) and overall survival (adjusted HR 8.14, P<0.001).

preprint2022arXiv

Benchmarking Deep Models for Salient Object Detection

In recent years, deep network-based methods have continuously refreshed state-of-the-art performance on Salient Object Detection (SOD) task. However, the performance discrepancy caused by different implementation details may conceal the real progress in this task. Making an impartial comparison is required for future researches. To meet this need, we construct a general SALient Object Detection (SALOD) benchmark to conduct a comprehensive comparison among several representative SOD methods. Specifically, we re-implement 14 representative SOD methods by using consistent settings for training. Moreover, two additional protocols are set up in our benchmark to investigate the robustness of existing methods in some limited conditions. In the first protocol, we enlarge the difference between objectness distributions of train and test sets to evaluate the robustness of these SOD methods. In the second protocol, we build multiple train subsets with different scales to validate whether these methods can extract discriminative features from only a few samples. In the above experiments, we find that existing loss functions usually specialized in some metrics but reported inferior results on the others. Therefore, we propose a novel Edge-Aware (EA) loss that promotes deep networks to learn more discriminative features by integrating both pixel- and image-level supervision signals. Experiments prove that our EA loss reports more robust performances compared to existing losses.